Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Evommune, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed CSU diagnosis for at least 3 months with an inadequate response to H1-antihistamines.
Subjects who are taking H1-antihistamines must be on a stable regimen 4 weeks prior to Day 1 and while on study.
Urticaria Activity Score (UAS7) equal to or greater than 16 at Day 1. UAS entries must be completed for a minimum of 4 out of the 7 days prior to Day 1.
You may not be if
Any clinically significant abnormality in laboratory evaluations, physical examinations, vital signs, or ECG at Screening, according to the Investigator's discretion.
Use of certain medications.
History of diseases with urticaria or angioedema symptoms, other than CSU and symptomatic dermographism.
Significant medical history other than CSU, or any other condition which might interfere with the evaluation of CSU.
Clareo Health | Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
